FDA and outliers [Study As­sess­ment]

posted by mittyri – Russia, 2018-12-11 17:38 (2015 d 23:22 ago) – Posting: # 19681
Views: 8,763

Dear Mann,

I don't think the position of FDA is different.
Please see this old post.

Do you have any experience of BEQ analysis for submission in FDA/EMA jurisdiction?
Where is the idea of outliers coming from?
Do the results without any outliers analysis also show not-BE?

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
26 visitors (0 registered, 26 guests [including 5 identified bots]).
Forum time: 18:00 CEST (Europe/Vienna)

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5